Ventas Reports First Quarter FFO of $0.35 Per Share

2003 FFO Increases 9 Percent Over 2002 First Quarter

LOUISVILLE, KY (April 29, 2003) - Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") said today that normalized Funds From Operations ("FFO") for the first quarter 2003 was $27.9 million or $0.35 per diluted share compared with $22.1 million or $0.32 per diluted share for the comparable 2002 period.

Net income for the first quarter ended March 31, 2003 was $37.3 million or $0.47 per diluted share. Net income includes a benefit of $20.2 million ($0.26 per diluted share) resulting from the reversal of a previously recorded contingent liability relating to uncertainties surrounding matters pertaining to an IRS audit of the Company's 1997-1998 tax periods that was completed on April 1, 2003. For the first quarter ended March 31, 2002, net income was $12.7 million or $0.18 per diluted share.

Normalized FFO for the first quarter ended March 31, 2003 excludes the $20.2 million impact of the reversal of the contingent liability.

"Ventas continues to produce reliable growth, delivering a nine percent increase in FFO during the first quarter," Ventas Chairman, President and CEO Debra A. Cafaro said. "Additionally, we continue to work with our primary tenant, Kindred Healthcare, Inc. (Nasdaq:KIND), to help Kindred achieve an orderly exit from the Florida skilled nursing home market on terms that are consistent with our Master Leases and beneficial to both companies."

FIRST QUARTER HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

  • The Company and Kindred distributed approximately $13 million to each company from a previously established Tax Refund Escrow which was a result of the successful completion of the IRS audit regarding the Company's 1997 and 1998 tax periods. The audit concluded that the Company (1) does not owe any additional taxes for those periods, (2) is entitled to retain the approximately $26 million federal tax refund it received in 1999 for those periods, and (3) is entitled to receive an additional refund of $1.2 million for those periods. In addition, as a result of the completion of the audit, the Company will retain substantially all of its favorable tax attributes such as net operating loss carryforwards and capital loss carryforwards.
  • Ventas increased its first quarter dividend to $0.2675 per share, a 13% increase over prior year quarterly dividend of $0.2375 per share.
  • Kindred's EBITDAR to rent coverage at the 253 skilled nursing facilities and hospitals it leases from the Company was 1.7x for the year ended December 31, 2002.
  • Rating agencies Moody's and S & P recently reconfirmed the Company's unsecured debt rating at Ba3/BB-. Moody's improved the outlook for the Company to "stable."

FIRST QUARTER 2003 RESULTS

Revenue for the quarter ended March 31, 2003, was $50.4 million, of which $47.1 million (or 93.5%) resulted from leases with Kindred. Expenses for the quarter ended March 31, 2003 totaled $13.1 million and were reduced by the $20.2 million of reversal of a contingent liability, and included $10.8 million of depreciation expense, $17.1 million of interest expense on debt financing, and $1.2 million of interest expense on the Company's settlement with the Department of Justice. General, administrative and professional expenses for the first quarter totaled $3.9 million.

FFO GUIDANCE

Ventas said it reaffirmed its 2003 normalized FFO guidance of $1.43 to $1.45 per diluted share. The guidance excludes gains and losses, the non-cash effect of swap ineffectiveness under SFAS 133 and the impact of acquisitions, divestitures and other capital transactions. The Company may from time to time update its publicly announced FFO guidance, but it is not obligated to so.

The Company's FFO guidance is based on a number of assumptions, which are subject to change and many of which are outside the control of the Company. If any of these assumptions vary, the Company's results may change. There can be no assurance that the Company will achieve these results.

FIRST QUARTER CONFERENCE CALL

The Company will hold a conference call to discuss this earnings release today, April 29, 2003, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The conference call is being web cast by CCBN and can be accessed at the Ventas website at www.ventasreit.com or www.companyboardroom.com. An online replay of the web cast will be available at approximately 12:00 p.m. Eastern time and will be archived for thirty (30) days.

Ventas, Inc. is a healthcare real estate investment trust that owns 44 hospitals, 220 nursing facilities and nine other healthcare and senior housing facilities in 37 states. The Company also has investments in 25 additional healthcare and senior housing facilities. More information about Ventas can be found on its website at www.ventasreit.com.

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements regarding Ventas, Inc.'s ("Ventas" or the "Company") and its subsidiaries' expected future financial position, results of operations, cash flows, funds from operations, dividends and dividend plans, financing plans, business strategy, budgets, projected costs, capital expenditures, competitive positions, growth opportunities, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations and statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements. Such forward-looking statements are inherently uncertain, and security holders must recognize that actual results may differ from the Company's expectations. The Company does not undertake a duty to update such forward-looking statements.

Actual future results and trends for the Company may differ materially depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission (the "Commission"). Factors that may affect the plans or results of the Company include, without limitation, (a) the ability and willingness of Kindred Healthcare, Inc. ("Kindred") and certain of its affiliates to continue to meet and/or perform their obligations under their contractual arrangements with the Company and the Company's subsidiaries, including without limitation the lease agreements and various agreements (the "Spin Agreements") entered into by the Company and Kindred at the time of the Company's spin-off of Kindred on May 1, 1998 (the "1998 Spin Off"), as such agreements may have been amended and restated in connection with Kindred's emergence from bankruptcy on April 20, 2001, (b) the ability and willingness of Kindred to continue to meet and/or perform its obligation to indemnify and defend the Company for all litigation and other claims relating to the healthcare operations and other assets and liabilities transferred to Kindred in the 1998 Spin Off, (c) the ability of Kindred and the Company's other operators to maintain the financial strength and liquidity necessary to satisfy their respective obligations and duties under the leases and other agreements with the Company, and their existing credit agreements, (d) the Company's success in implementing its business strategy, (e) the nature and extent of future competition, (f) the extent of future healthcare reform and regulation, including cost containment measures and changes in reimbursement policies and procedures, (g) increases in the cost of borrowing for the Company, (h) the ability of the Company's operators to deliver high quality care and to attract patients, (i) the results of litigation affecting the Company, (j) changes in general economic conditions and/or economic conditions in the markets in which the Company may, from time to time, compete, (k) the ability of the Company to pay down, refinance, restructure, and/or extend its indebtedness as it becomes due, (l) the movement of interest rates and the resulting impact on the value of the Company's interest rate swap agreements and the Company's net worth, (m) the ability and willingness of the Company to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations, including without limitation, the risk that the Company may fail to qualify as a REIT due to its ownership of common stock in Kindred (“Kindred Common Stock”), (n) final determination of the Company's taxable net income for the years ending December 31, 2002 and December 31, 2003, (o) the ability and willingness of the Company's tenants to renew their leases with the Company upon expiration of the leases and the Company's ability to relet its properties on the same or better terms in the event such leases expire and are not renewed by the existing tenants, (p) the impact on the liquidity, financial condition and results of operations of Kindred and the Company's other operators resulting from increased operating costs and uninsured liabilities for professional liability claims, particularly in the state of Florida, and the ability of Kindred and the Company's other operators to accurately estimate the magnitude of such liabilities, and (q) the value of the Company's Kindred Common Stock and the limitations on the ability of the Company to sell, transfer or otherwise dispose of its common stock in Kindred arising out of the securities laws and the registration rights agreement the Company entered into with Kindred and certain of the holders of common stock in Kindred. Many of such factors are beyond the control of the Company and its management.

                 CONDENSED CONSOLIDATED BALANCE SHEETS
                 March 31, 2003 and December 31, 2002
                            (In thousands)

                                                March 31,   December
                                                    2003        31,
                                                               2002
                                                ----------- ----------
                                                (Unaudited) (Audited)
Assets
Real estate investments:
   Land                                           $119,559   $119,559
   Building and improvements                     1,101,847  1,101,847
                                                ----------- ----------
                                                 1,221,406  1,221,406
   Accumulated depreciation                       (419,868)  (409,132)
                                                ----------- ----------
       Total net real estate property              801,538    812,274
         Loan receivable, net                       16,505     16,528
                                                ----------- ----------
                Total net real estate
                 investments                       818,043    828,802
Cash and cash equivalents                            3,083      2,455
Restricted cash.                                    19,575     19,953
Deferred financing costs, net                       16,684     17,704
Investment in Kindred Healthcare, Inc. common
 stock                                              10,414     16,713
Notes receivable from employees, former
 employees and accrued interest                      4,158      4,139
Other                                                6,137      6,014
                                                ----------- ----------
       Total assets                               $878,094   $895,780
                                                =========== ==========
Liabilities and stockholders' equity (deficit)
Liabilities:
   Senior Notes payable and other debt            $750,442   $707,709
   United States Settlement                         41,120     43,992
   Securities settlement due (purchase of Senior
    Notes)                                              --     37,366
        Deferred revenue                            18,248     18,883
   Interest rate swap agreements                    47,499     47,672
   Accrued dividend                                     --     16,596
   Accrued interest                                 15,116      7,237
   Accounts payable and other accrued
    liabilities                                     17,769     25,402
   Other liabilities--disputed federal, state
    and local tax refunds                              272     14,156
   Deferred income taxes                            30,394     30,394
                                                ----------- ----------
       Total liabilities                           920,860    949,407
                                                ----------- ----------

Commitments and contingencies

Stockholders' equity (deficit):
   Preferred stock, unissued                            --         --
   Common stock                                     20,652     20,652
   Capital in excess of par value                  188,992    191,779
   Unearned compensation on restricted stock.       (1,730)      (793)
   Accumulated other comprehensive loss            (32,574)   (26,116)
   Retained earnings (deficit)                    (118,137)  (134,279)
                                                ----------- ----------
                                                    57,203     51,243
   Treasury stock                                  (99,969)  (104,870)
                                                ----------- ----------
       Total stockholders' equity (deficit)        (42,766)   (53,627)
                                                ----------- ----------

       Total liabilities and stockholders'
        equity (deficit)                          $878,094   $895,780
                                                =========== ==========


              CONDENSED CONSOLIDATED STATEMENTS OF INCOME
            For Three Months Ended March 31, 2003 and 2002
               (In thousands, except per share amounts)
                              (Unaudited)


                                                         2003    2002
                                                      ----------------
Revenues:
   Rental income                                      $49,184 $46,102
   Interest income from loan receivable                   747      --
   Interest and other income                              492     342
                                                      ----------------
       Total revenues                                  50,423  46,444
                                                      ----------------
Expenses:
   General and administrative                           3,140   2,311
   Professional fees                                      760     565
   Reversal of contingent liability                   (20,164)     --
   Amortization of restricted stock grants                291     422
   Depreciation                                        10,801  10,405
   Interest                                            17,125  19,740
   Interest on United States Settlement                 1,182   1,471
                                                      ----------------
       Total expenses                                  13,135  34,914
                                                      ----------------
Income before discontinued operations                  37,288  11,530
Discontinued operations (including gain on sale of
 assets)                                                   --   1,171
                                                      ----------------
Net income                                            $37,288 $12,701
                                                      ================
Earnings per common share:
   Basic:
       Income before discontinued operations            $0.47   $0.16
       Net income                                       $0.47   $0.18

   Diluted:
       Income before discontinued operations            $0.47   $0.16
       Net income                                       $0.47   $0.18

Weighted average number of shares outstanding, basic   78,834  68,698
Weighted average number of shares outstanding,
 diluted                                               79,296  69,844

Dividends declared per common share                   $0.2675 $0.2375


            CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
          For the Three Months Ended March 31, 2003 and 2002
                            (In thousands)
                              (Unaudited)

                                                         2003    2002
                                                    ------------------
Cash flows from operating activities:
   Net income                                         $37,288 $12,701
   Adjustments to reconcile net income to net cash
    provided by
     operating activities:
       Depreciation (including discontinued
        operations)                                    10,801  10,466
       Amortization of deferred financing costs         1,020     700
       Amortization of restricted stock grants            291     422
       Normalized rents                                   (43)    (48)
       Gain on sale of assets (included in
        discontinued
         operations in 2002)                               --  (1,057)
       Amortization of deferred revenue                  (666)   (627)
       Other                                              (54)     38
   Changes in operating assets and liabilities:
     Decrease in restricted cash                          378     779
     Increase in other assets                            (914)   (254)
     Increase in accrued interest                       7,879     924
     Increase (decrease) in accounts payable and
      accrued and other
         liabilities                                  (20,134)    134
                                                    ------------------
           Net cash provided by operating
            activities                                 35,846  24,178
Cash flows from investing activities:
   Proceed from sale of real estate                        --   1,550
   Collection from loan receivable                         54      --
   Purchase of furniture and equipment                    (41)    (76)
   Increase in notes receivable from employees,
    former employees and
     accrued interest                                     (19)   (873)
                                                    ------------------
           Net cash provided by (used in) investing
            activities                                     (6)    601
Cash flows from financing activities:
   Net change in borrowings under Revolving Credit
    Facility                                           43,350      --
   Purchase of Senior Notes                           (37,366)     --
   Repayment of long-term debt                           (617)(16,824)
        Payment on United States Settlement            (2,872)     --
   Proceeds from (cost of) issuance of stock               35     (40)
   Cash dividends to stockholders                     (37,742)(17,230)
                                                    ------------------
           Net cash used in financing activities      (35,212)(34,094)
                                                    ------------------
Increase (decrease) in cash and cash equivalents          628  (9,315)
Cash and cash equivalents at beginning of period        2,455  18,596
                                                    ------------------
Cash and cash equivalents at end of period             $3,083  $9,281
                                                    ==================

                           SUPPLEMENTAL DATA

Funds from Operations

FFO and Normalized FFO for the three months ended March 31, 2003
and 2002 (in thousands except per share amounts):

                                                         2003    2002
                                                      ----------------

  Net Income                                          $37,288 $12,701
  Adjustments:
   Depreciation on real estate assets                  10,736  10,363
  Other Items:
  Discontinued operations:
   Real estate depreciation - discontinued                 --      61
   Gain on sale of real estate                             --  (1,057)
                                                      ----------------
  FFO                                                  48,024  22,068

  Reversal of contingent liability                    (20,164)     --
                                                      ----------------
  Normalized FFO                                      $27,860 $22,068
                                                      ----------------

Per diluted share:
  Net Income                                            $0.47   $0.18
  Adjustments:
   Depreciation on real estate assets                    0.14    0.15
  Other items:
  Discontinued operations:
   Real estate depreciation - discontinued                 --      --
   Gain on sale of real estate                             --   (0.01)
                                                      ----------------
FFO                                                      0.61    0.32

Reversal of contingent liability                        (0.26)     --
                                                      ----------------
  Normalized FFO                                        $0.35   $0.32
                                                      ================


Projected FFO for the year ended December 31, 2003 (in millions
except per share amounts):

                                                       2003 Projected
                                                      ----------------
Per diluted share:
Net income                                             $1.15 -  $1.17
Adjustments:
   Depreciation on real estate assets                   0.54 -   0.54
                                                      -------  -------
FFO                                                    $1.69 -   1.71

Adjustments:
   Reversal of contingent liability                    (0.26)-  (0.26)
                                                      -------  -------
Normalized Funds from Operations                       $1.43 -  $1.45
                                                      =======  =======

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen or fallen with market conditions, many industry investors have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. To overcome this problem, the Company considers an appropriate measure of performance of an equity REIT and uses the National Association of Real Estate Investment Trusts ("NAREIT") definition of FFO. NAREIT defines FFO as net income (computed in accordance with generally accepted accounting principles), excluding gains (or losses) from sales of property, plus depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect funds from operations on the same basis.

FFO presented herein is not necessarily comparable to FFO presented by other real estate companies due to the fact that not all real estate companies use the same definition. FFO should not be considered as an alternative to net income (determined in accordance with accounting principles generally accepted in the United States ("GAAP")), as an indicator of the Company's financial performance, as an alternative to cash flow from operating activities (determined in accordance with GAAP), as a measure of the Company's liquidity, nor is FFO necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO should be examined in conjunction with net income as presented elsewhere in this Press Release.

Portfolio of Properties

The following information provides an overview of the Company's
portfolio of healthcare properties as of and for three months ended
March 31, 2003 ($'s in thousands):

                               As of and for the First Quarter Ended
                                           March 31, 2003
                              ----------------------------------------
                                 # of     # of          Percent  # of
      Portfolio by Type        Properties  Beds Revenue    of   States
                                                         Revenue
----------------------------------------------------------------------
Healthcare Property
Skilled Nursing Facilities           220 27,840 $33,410      68%   32
Hospitals                             44  3,923  15,496      31%   20
Other Facilities                       9    181     278       1%    2
                                   ----------------------------------
     Total Rental Income             273 31,944 $49,184     100%   37
                                   ==================================
Other Real Estate Investments
Loan Receivable                       25  1,982    $747
                                   ==========================

Kindred Coverage Ratios

The following is based on data provided by Kindred to the Company
or obtained from Kindred's public filings. This information reflects
Kindred's EBITDAR coverage by Master Lease after management fees:

                 TTM (1)
 Master        EBITDAR
   Lease      Coverage (2,3)
----------   -------------
        1             1.9
        2             1.6
        3             1.7
        4             1.6
        5             1.8
--------------------------
Portfolio             1.7
--------------------------
  • (1) Trailing Twelve Months EBITDAR ended December 31, 2002 (the latest available data provided by Kindred) to the Company's Trailing Twelve Months rental revenue.
  • (2) Coverage reflects the ratio of EBITDAR to rent. EBITDAR is defined as earnings before interest, income taxes, depreciation, amortization and rent but after deducting management fees. EBITDAR is adjusted to normalize Kindred professional liability expense. Kindred charged additional liability expense of $55 million in the third quarter and $19 million in the fourth quarter totaling $74 million. It disclosed that the additional charges included $30 million related to 2001 and $44 million related to 2002. This reallocation of Ventas' portion of the $30 million to 2001 had the effect of increasing Kindred's reported 2002 EBITDAR by approximately $27 million, which is reflected in the coverage computations.
  • (3) These computations reflect the fourth quarter impact of the reduction in Medicare reimbursement to skilled nursing facilities, which took effect October 1, 2002
Scheduled Maturities of Borrowing Arrangements

The Company's indebtedness has the following maturities (in
thousands):

2003                                         $2,392
2004                                          3,412
2005                                        106,490
2006                                        214,810
2007                                         57,300
Thereafter                                  366,038
                                       -------------
   Total                                   $750,442
                                       =============